Intestinal Microbiota Transplant Prior to Allogeneic Stem Cell Transplant (MAST) trial: study protocol for a multicentre, double-blinded, placebo-controlled, phase IIa trial
Introduction Lower diversity of the gut microbiome prior to allogeneic haematopoietic cell transplantation (HCT) correlates with reduced survival after the intervention. Most patients undergoing HCT for a haematological malignancy have previously received intensive chemotherapy, resulting in prolong...
Saved in:
| Main Authors: | Julian R Marchesi, Emma Nicholson, Benjamin H Mullish, Renuka Palanicawandar, Graham Wheeler, Francesca Kinsella, Andrew J Innes, Lauren A Roberts, Shian Anim-Burton, Lee Webber, Nicholas A Johnson, Rohma Ghani, Pakhshan Farshi, Anjum B Khan, Panagiotis Kottaridis, Pramila Krishnamurthy, Frances Davies, Jiří Pavlů |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
BMJ Publishing Group
2024-12-01
|
| Series: | BMJ Open |
| Online Access: | https://bmjopen.bmj.com/content/14/12/e093120.full |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
The potential utility of fecal (or intestinal) microbiota transplantation in controlling infectious diseases
by: Rohma Ghani, et al.
Published: (2022-12-01) -
FAecal micRobiota transplantation in primary sclerosinG chOlangitis (FARGO): study protocol for a randomised, multicentre, phase IIa, placebo-controlled trial
by: Laith Alrubaiy, et al.
Published: (2025-01-01) -
Transplant Trial Watch
by: John O’Callaghan, et al.
Published: (2025-05-01) -
Transplant Trial Watch
by: Simon R. Knight, et al.
Published: (2025-02-01) -
Transplant Trial Watch
by: John M. O’Callaghan, et al.
Published: (2025-01-01)